Abstract
Background:
Accurate severity assessment is crucial to the initial management of community-acquired pneumonia (CAP). The CURB-65 (confusion, uremia, respiratory rate, BP, age ≥ 65 years) score contains data that are entered routinely in electronic medical records and are, thus, electronically calculable. The aim of this study was to determine whether an electronically generated severity estimate using CURB-65 elements as continuous and weighted variables better predicts 30-day mortality than the traditional CURB-65.
Methods:
In a retrospective cohort study at a US university-affiliated community teaching hospital, we identified 2,069 patients aged 18 years or older with CAP confirmed by radiographic findings in the ED. CURB-65 elements were extracted from the electronic medical record, and 30-day mortality was identified with the Utah Population Database. Performance of a severity prediction model using continuous and weighted CURB-65 variables was compared with the traditional CURB-65 in the US derivation population and validated in the original 1,048 patients from the CURB-65 international derivation study.
Results:
The traditional, binary CURB-65 score predicted mortality in the US cohort with an area under the curve (AUC) of 0.82. Our severity prediction model generated from continuous, weighted CURB-65 elements was superior to the traditional CURB-65, with an out-of-bag AUC of 0.86 (P < .001). This finding was validated in the international database, with an AUC of 0.85 for the electronic model compared with 0.80 for the traditional CURB-65 (P = .01).
Conclusions:
Using CURB-65 elements as continuous and weighted data improved prediction of 30-day mortality and could be used as a real-time, electronic decision support tool or to adjust outcomes by severity when comparing processes of care.
Community-acquired pneumonia (CAP), along with influenza, is the eighth leading cause of death in the United States.1 About 6 million cases are reported annually, resulting in an estimated 500,000 to 1.1 million hospitalizations.2,3 Treatment costs $8.4 billion to $10 billion annually, with the cost of inpatient care 25 times that of outpatient care.3 The outcome of CAP is extremely variable and depends upon the affected host’s response, the underlying pathogen, and the treatment delivered. Site of care is a major decision in the management of pneumonia and is guided by estimated severity of the patient’s disease.4,5 However, variability in physician decision making regarding the need for hospital admission has been repeatedly demonstrated.6-8 Therefore, accurate severity assessment during initial management is critical.
Two severity assessment tools have become widely used by clinicians to help distinguish high-risk patients who require inpatient management from those able to thrive with outpatient management. The pneumonia severity index (PSI) developed by Fine and colleagues9 is a prognostic model that calculates a severity-of-illness score based on 20 separate patient characteristics, including underlying comorbidities. The CURB-65 score is composed of five separate elements: confusion, uremia, respiratory rate, BP, and age ≥ 65 years (Table 1). This was initially developed by the British Thoracic Society in 1987 as the CRB criteria,10 later modified to the CURB-65 and validated by Lim et al11 in an international, multicenter derivation/validation study from Nottingham, England; Christchurch and Waikato, New Zealand; and Alkmaar, The Netherlands.
Table 1.
Confusion |
Abbreviated mental score ≤ 8 or orientation < 3 (time, place, self) |
BUN ≥ 20 mg/dL |
Respiratory rate ≥ 30 breaths/min |
Systolic BP < 90 mm Hg or diastolic BP < 60 mm Hg |
Age ≥ 65 years |
Score of 0 or 1: mild to moderate CAP. Need additional assessment but may consider outpatient management. |
Score of ≥ 2: severe CAP. Recommend hospitalization. |
Data from Reference 2. CAP = community-acquired pneumonia; CURB-65 = confusion, uremia, respiratory rate, BP, age > 65 years.
Both the PSI and the CURB-65 are accepted methods of assessing severity by the American Thoracic Society4; the British Thoracic Society recommends use of the CURB-65.5 Although the PSI has been shown to be slightly more accurate at predicting outcome,12-16 CURB-65 is simpler to use. Additionally, all elements of the CURB-65 are routinely entered into the electronic medical record, making it possible to generate a mortality prediction automatically for each patient at the point of care.
CURB-65 attributes a point to each criterion in a dichotomous and equally weighted fashion. However, excluding confusion, CURB-65 elements are actually continuous variables that may not be of equal predictive value. CURB-65, therefore, may be more accurate if calculated with continuous and weighted variables. Instead of a severity score, a computer could generate an individualized mortality risk estimate using data elements from the electronic medical record. Generating an automated, accurate mortality estimate immediately available to providers could improve severity assessment and thus improve care.
Our aims were to:
1. Validate the CURB-65 severity assessment tool in patients with CAP presenting to a US ED using information from the electronic medical record.
2. Examine whether a computer-generated CURB-65 using continuous and weighted variables available electronically (e-Table 1) improves accuracy in mortality prediction over the traditional dichotomous CURB-65.
3. Validate our derived severity prediction model in an international multicenter database of patients with pneumonia.11
Materials and Methods
Study Population
The study was performed at Latter-day Saints (LDS) Hospital, a university-affiliated community teaching hospital in Salt Lake City, Utah, with 520 beds. An electronic medical record was implemented in the ED in 1995, followed that same year by a paper-based, standardized pneumonia treatment protocol.17
In a retrospective analysis of data in the electronic medical record, we identified all patients > 18 years of age evaluated in the ED at LDS Hospital from 1996 to 2006 with International Statistical Classification of Diseases, 9th edition (ICD-9) codes specific for a primary diagnosis of pneumonia (480-487.1), or respiratory failure or sepsis (518.x, 038.x) as a primary diagnosis with pneumonia secondary. Patients diagnosed with aspiration pneumonia (507.0), immunocompromised conditions including AIDS or receipt of antiretroviral therapy (042), solid organ transplants (v420-7), hematologic malignancies (v106.x, 200.x, 208.x), and those meeting criteria for health-care-associated pneumonia18 were excluded. We included only the first episode of pneumonia in a given 12-month period; however, 45 individuals presented with more than one case of pneumonia outside a 12-month period. Chest radiograph and CT scan reports upon admission to the ED were manually reviewed for radiographic evidence of pneumonia by three physicians, with a three-way κ agreement score of 0.95 for a random sample of 100 reports. Patients lacking radiographic evidence for pneumonia were excluded. This study was approved by the LDS Hospital institutional review board and the Utah Population Database. Patient consent was not required.
Validation Cohort
Patient records contained in the database from the prior international CURB-65 derivation and validation study11 were used to validate the model derived in our population. The study included patients with CAP in England, The Netherlands, and New Zealand. Exclusion criteria were similar to our study, with the exception that only patients admitted to the hospital as an emergency were included. Data for calculation of CURB-65 were recorded prospectively upon hospital admission, with 30-day all-cause mortality determined during follow-up.
Measurements
The first 6 hours of vital signs, orientation status (entered routinely during nursing assessment), and the first 12 hours of routine laboratory results were extracted from the electronic medical record. A manual review of 50 charts showed > 90% agreement between electronic and paper records; the majority of the disagreements were minor discrepancies in BP that were not significant enough to result in a change in CURB-65 classification. The methodology of an electronic, continuous-weighted CURB-65 requires a specific value for BUN. The PSI and CURB-65 conventionally assume normality for missing data. Additionally, CRB-65 has been validated as a predictive score for patients lacking a BUN.11,15,19 Of the 304 patients missing BUN values, 268 were not admitted to the hospital. Therefore, for patients lacking a BUN determination, we imputed a median BUN matched by age quartile derived from nonadmitted patients in our cohort (e-Table 2). This same imputation was applied to the 40 patients with missing BUN values in the validation cohort. The outcome measure of 30-day all-cause mortality was determined by both the Intermountain Healthcare electronic database and the Utah Population Database.20
Because many patients had several measurements of CURB elements during their ED evaluation, we created summary measures (first, last, minimum, and maximum) to determine which measure to carry forward. The summary measure for each element was selected in a forward stepwise selection procedure using out-of-bag area under the curve (AUC) for the receiver operating characteristic as a selection criterion. The first measurements of vital signs and orientation status performed as well or better than subsequent measurements and were thus used in the analysis. Additionally, systolic BP was used, as it was found to be nonsignificantly better than diastolic BP, and the latter did not add any additional predictive value.
Statistical Analysis
In the derivation (US) cohort, we compared 30-day mortality for the CURB-65 model vs a lasso penalized logistic regression model. Nonlinear effects were expected for CURB-65 elements, so natural cubic splines with three knots were applied to the BUN, respiratory rate, BP, and age elements. The lasso penalty (L1-5) was imposed on the logistic regression parameters to prevent overfitting, especially at extreme values and after using spline transforms.21
In order to avoid overestimating modeling performance during the derivation phase, the prediction modeling strategy was evaluated within the derivation cohort using a bootstrap sampling method.22 The method resulted in 63.2% of the original observations (“in-the-bag”) available to construct the logistic regression model and 36.8% of observations withheld (“out-of-bag”) for assessing predictive performance across each of 1,000 iterations. The final model sent to the international cohort for validation was based on the entire US derivation cohort. Receiver operating characteristic curves and P values for differences between the discrete CURB-65 score and the logistic regression model were then calculated and compared between the US and the international cohorts.23,24 Analyses were performed using the R statistical package, version 2.9 (www.r-project.org).25
Results
We identified 4,973 cases; 3,289 of those had radiographic evidence of pneumonia. We excluded 621 for risk factors for health-care-associated pneumonia and previous diagnosis of pneumonia within 1 year. Restricting the study population to patients evaluated in the ED reduced the number to 2,076 cases in 2,027 patients. Seven patients lacked an electronic record of orientation, respiratory rate, or systolic BP during the 6-h time window, and were, therefore, excluded from analysis. The resulting study population comprised 2,069 cases, of which 58% resulted in admission to the hospital (Fig 1). In the validation cohort, 20 patients lacked a vital sign and were thus excluded from the comparison.
Seventy percent of the patients in the LDS Hospital cohort presented with a CURB-65 score of 0 or 1. The mean age was 57 years, and 48% were women. Compared with the international CURB-65 validation study, our study population was younger (mean age 57 vs 64 years, P < .001 by Welch t test), had a lower mortality rate (4.1% vs 9.1%, P < .001 by Fisher exact test), and included patients discharged from the ED as well as those admitted to the hospital (Table 2). Of the patients from our study population who were admitted to the hospital, the age (64 years, SD 19 years) and mortality rate (6.8%) were not significantly different from the international study population (P = .931 and .059, respectively, by Fisher exact test).
Table 2.
US Cohort |
||||
Measure | Total | Inpatients | Outpatients | International Cohort |
Study population, No. (%) | 2,069 | 1,199 (58) | 87 (42) | 1,048 |
Mean age, y (SD) | 57 (18) | 63 (18) | 46 (18) | 64 (18) |
% Women | 48.0 | 48.8 | 47.2 | 48.5 |
30-d Mortality, % (CI) | 4.1 (3.3-5.1) | 6.80 (5.48-8.42) | 0.34 (0.07-1.00) | 9 (7.4-11.0) |
A strong relationship between mortality and CURB-65 score was demonstrated, with a mortality rate of 2.1% for patients with a CURB-65 score of 1 vs 7.7% for those with a CURB-65 score of 2. This relationship was similar to that found in the international cohort (Fig 2).
Effect plots26 for the CURB-65 elements are shown in Figure 3. CURB-65 thresholds are represented by a vertical line. The effect plots for age, BUN, and respiratory rate suggest polytonic relationships with 30-day mortality; few patients had extreme values and the confidence intervals at these points are wide.
Figure 4A shows the performance of the dichotomous CURB-65 (AUC = 0.82) compared with the penalized logistic regression model using continuous, spline transformed values (AUC = 0.87) for the LDS Hospital data (P < .001) The AUC is known to be overestimated using the same data to train and test the model. The out-of-bag AUC estimate for the logistic regression model was 0.86 (95% CI, 0.80-0.91).
Figure 4B shows the performance of the CURB-65 score (AUC = 0.80) compared with the model derived from the LDS Hospital data and applied to the international data (AUC = 0.85). This shows a statistically significant improvement in predictive performance (P = .01). Our derived electronic CURB-65 model is available in e-Tables 1-4 for application.
Discussion
Our study demonstrates that the traditional CURB-65 pneumonia severity score reliably predicts 30-day all-cause mortality in a large population of ED patients with pneumonia in a North American community teaching hospital, comparable to results obtained abroad. This validation was achieved using data elements routinely entered in the electronic medical record. We were able to improve this predictive power by preserving the continuous nature of BUN, respiratory rate, BP, and age. We have validated this approach in an independent, prospectively identified, and more severely ill population in an international pneumonia database.11
This more accurate pneumonia severity prediction model (hereafter referred to as eCURB) could be implemented as a real-time, electronic decision support tool. In contrast to the PSI, no predictors beyond those routinely present in the electronic record are required. The eCURB calculates a point estimate of 30-day mortality, instead of lumping mortality risk into dichotomous categories. Patients whose data are near the dichotomous cutpoints may be more accurately assessed with eCURB than CURB-65. For example, a 62-year-old man who is oriented × 3 with a BUN of 44 mg/dL, a BP of 95/65 mm Hg, and a respiratory rate of 28/min, although scoring 1 by the CURB-65 (mortality rate 2%), would generate a 30-day mortality estimate of 14% by the eCURB. The eCURB method is contained in e-Tables 1-4, which allows the user to enter values to estimate 30-day mortality. We believe that eCURB will be most useful as a method of severity assessment for a personal data assistant or automated as part of a real-time electronic medical record. The methodology is simple enough to be widely used in different electronic platforms, not confined to EDs with fully electronic medical records. A more accurate, fully automated severity assessment tool is likely to be more useful to clinicians than less accurate tools that require hand calculation.27 The eCURB has the additional potential to be adapted to risk stratifications and admission thresholds specific to different populations.
Additional variables found to influence mortality, such as the ratio of oxygen saturation by pulse oximetry to Fio2,4 could also be added to further improve mortality prediction. However, we chose to focus on the five CURB-65 variables because of the established nature of this score and because the international validation database does not consistently contain oxygenation data.
Electronic severity prediction could be integrated with other guideline elements in a clinical decision support tool available at the point of care. Although the pneumonia guideline implementation in our health-care system has been more successful than most,28 provider use of severity assessment as a decision support tool has lagged behind use of other guideline elements. Automatic calculation of individualized risk prediction as part of a comprehensive decision support tool that can be adapted to local needs could be an important strategy for local implementation of national pneumonia treatment guidelines, as recommended by the British Thoracic Society, the Infectious Diseases Society of America, and the American Thoracic Society.4,5 The ultimate clinical decision support tool would integrate severity assessment and triage recommendations with additional management guidelines, such as antibiotic selection and duration.
Beyond decision support, the eCURB could also be used to improve severity adjustment methods when comparing quality of care between hospitals. The US Center for Medicare Service’s Hospital Compare (www.hospitalcompare.hhs.gov) assesses outcomes and performance measures among hospitals, making results available to the public for common medical conditions, including CAP. However, analysis has shown only a modest relationship between adherence to performance measures and outcome, suggesting that attention should be focused on identifying measures more tightly linked to outcome.29 Hospital Compare makes risk adjustments using past medical history and comorbidities, but it does not adjust for severity of illness upon presentation. A more accurate severity-adjusted mortality estimate might improve comparisons of mortality in the absence of reliable performance measures. Calculating eCURB would require few additional resources compared with the current method of performance measurement.
Our ED database is distinct from many large pneumonia study populations.9,11 It includes not only hospital inpatients but also patients discharged home from the ED and managed as outpatients, thereby providing representation of patients with less severe disease. The cohort of patients used for validation of our prediction model contained only patients admitted to the hospital. Although both CURB-65 score and the eCURB had lower predictive performance in the international data, the relative superiority of the eCURB was similar in both cohorts.
Our study has limitations. It is retrospective and relies upon ICD-9 coding rather than prospective screening. In The Netherlands and Sweden, this methodology missed some pneumonias, particularly in patients with prolonged hospital admissions.30,31 In the United States and particularly in our hospital, however, ICD-9 codes have demonstrated reasonable sensitivity for diagnosis of CAP.32,33 The specificity of our technique was augmented by manual review of chest radiology reports. In addition, our use of real-time electronic charting for recording data significantly reduces the missing values generally associated with retrospective analyses. Validation of eCURB in the international database is also reassuring, as these patients were prospectively identified using different methodology. Our use of both Intermountain Healthcare and the Utah Population Databases to track statewide mortality further strengthens our analysis, although some out-of-state deaths may have escaped detection.
Calculation of CURB-65 using continuous and weighted variables is a logical extension of prior work, easily accomplished by a computer or personal digital assistant. Future research is directed toward further improving our model by integrating additional variables found to influence mortality, investigating performance of eCURB in predicting in-hospital mortality, length of stay, and the need for hospital admission. In addition, the improved severity estimate should be integrated into a real-time electronic pneumonia decision support tool, followed by implementation at the point of care. The ultimate test of electronic admission decision support will be to evaluate its influence on admission rate, mortality, length of stay, and cost.
Supplementary Material
Acknowledgments
Author contributions: Dr B. E. Jones: contributed as primary and corresponding author to study design, database refinement, model development, and manuscript preparation and revision.
Dr J. Jones: contributed to model derivation, statistical analysis, and manuscript revision.
Dr Bewick: contributed to validation of the cohort analysis and manuscript revision.
Dr Lim: contributed to validation of the cohort database and analysis and manuscript review.
Dr Aronsky: contributed to study design, derivation of the cohort database, and manuscript revision.
Dr Brown: contributed to derivation of the cohort database refinement, chest radiograph review, and manuscript revision.
Dr Boersma: contributed to validation of the cohort database and manuscript review.
Dr van der Eerden: contributed to validation of the cohort database and manuscript review.
Dr Dean: contributed as senior author to study design, database refinement, model development, and manuscript revision and approval.
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Lim has received an unrestricted educational grant from Wyeth/Pzier for clinical research. Dr Dean has received an unrestricted educational grant from Pfizer. He has also served on advisory boards for Forest, Merck, Ortho-McNeil, and Advanced Life Sciences. The remaining authors have reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or in the preparation of the manuscript.
Other contributions: We thank Al Jephson, BS, Susan Crapo, BS, and Joe Dalto, MS, for data extraction; Greg Snow, PhD, for preliminary statistical analyses; Marc-Aurel Martial, RN, for quality assurance; and Tamara Bracken, BA, for administrative support. We also thank R. Laing, N. Karalus, and G. I. Town for allowing and supporting further analysis of international data derived from their work.
Additional Information: The e-Tables can be found in the Online Supplement at http://chestjournal.chestpubs.org/content/140/1/156/suppl/DC1.
Abbreviations
- AUC
area under the curve
- CAP
community-acquired pneumonia
- CURB-65
confusion, uremia, respiratory rate, BP, age > 65 years
- ICD-9
International Statistical Classification of Diseases, 9th edition
- LDS
Latter-day Saints
- PSI
pneumonia severity index
Footnotes
Funding/Support: This research is supported by the Deseret Foundation of Salt Lake City, UT.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).
References
- 1.Center for Health Statistics Health, United States. May 20, 2010. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/data/nvsr58/nvsr58_19.pdf. Accessed January 9, 2011.
- 2.Marston BJ, Plouffe JF, File TM, Jr, et al. The Community-Based Pneumonia Incidence Study Group Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med. 1997;157(15):1709–1718. [PubMed] [Google Scholar]
- 3.Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20(4):820–837. doi: 10.1016/s0149-2918(98)80144-6. [DOI] [PubMed] [Google Scholar]
- 4.Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America American Thoracic Society Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–S72. doi: 10.1086/511159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lim WS, Baudouin SV, George RC, et al. Pneumonia Guidelines Commette of the BTS Standards of Care Committee British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(suppl III):iii1–iii55. doi: 10.1136/thx.2009.121434. [DOI] [PubMed] [Google Scholar]
- 6.McMahon LF, Jr, Wolfe RA, Tedeschi PJ. Variation in hospital admissions among small areas. A comparison of Maine and Michigan. Med Care. 1989;27(6):623–631. doi: 10.1097/00005650-198906000-00005. [DOI] [PubMed] [Google Scholar]
- 7.Rosenthal GE, Harper DL, Shah A, Covinsky KE. A regional evaluation of variation in low-severity hospital admissions. J Gen Intern Med. 1997;12(7):416–422. doi: 10.1046/j.1525-1497.1997.00073.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Halm EA, Atlas SJ, Borowsky LH, et al. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med. 2000;160(1):98–104. doi: 10.1001/archinte.160.1.98. [DOI] [PubMed] [Google Scholar]
- 9.Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi: 10.1056/NEJM199701233360402. [DOI] [PubMed] [Google Scholar]
- 10.The British Thoracic Society and the Public Health Laboratory Service Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med. 1987;62(239):195–220. [PubMed] [Google Scholar]
- 11.Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi: 10.1136/thorax.58.5.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118(4):384–392. doi: 10.1016/j.amjmed.2005.01.006. [DOI] [PubMed] [Google Scholar]
- 13.Buising KL, Thursky KA, Black JF, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006;61(5):419–424. doi: 10.1136/thx.2005.051326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Capelastegui A, España PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27(1):151–157. doi: 10.1183/09031936.06.00062505. [DOI] [PubMed] [Google Scholar]
- 15.Man SY, Lee N, Ip M, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax. 2007;62(4):348–353. doi: 10.1136/thx.2006.069740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ananda-Rajah MR, Charles PG, Melvani S, Burrell LL, Johnson PD, Grayson ML. Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scand J Infect Dis. 2008;40(4):293–300. doi: 10.1080/00365540701663381. [DOI] [PubMed] [Google Scholar]
- 17.Dean NC, Bateman KA. Local guidelines for community-acquired pneumonia: development, implementation, and outcome studies. Infect Dis Clin North Am. 2004;18(4):975–991. doi: 10.1016/j.idc.2004.07.005. [DOI] [PubMed] [Google Scholar]
- 18.Craven DE, Palladino R, McQuillen DP. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am. 2004;18(4):939–962. doi: 10.1016/j.idc.2004.08.001. [DOI] [PubMed] [Google Scholar]
- 19.Bauer TT, Ewig S, Marre R, Suttorp N, Welte T. CAPNETZ Study Group CRB-65 predicts death from community-acquired pneumonia. J Intern Med. 2006;260(1):93–101. doi: 10.1111/j.1365-2796.2006.01657.x. [DOI] [PubMed] [Google Scholar]
- 20.Skolnick M. The Utah genealogical database: a resource for genetic epidemiology. In: Cairns JL, Skolnick M, editors. Banbury Report No 4; Cancer Incidence in Defined Populations. New York, NY: Cold Spring Harbor Laboratory; 1980. pp. 285–297. [Google Scholar]
- 21.Tibshirani R. Regression shrinkage and selection via the LASSO. J R Stat Soc Series B Stat Methodol. 1996;;58(1):267–288. [Google Scholar]
- 22.Efron B, Tibshirani R. Improvements on cross-validation: the 632+ bootstrap method. J Am Stat Assoc. 1997;92(438):548–560. [Google Scholar]
- 23.DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. [PubMed] [Google Scholar]
- 24.Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi: 10.1148/radiology.143.1.7063747. [DOI] [PubMed] [Google Scholar]
- 25.Vienna, Austria: R Foundation for Statistical Computing; 2009. R: A Language and Environment for Statistical Computing. Version v2.9.1. [Google Scholar]
- 26.Fox J. Effect displays in R for generalised linear models. J Stat Softw. 2003;8(15):1–27. [Google Scholar]
- 27.Lee RW, Lindstrom ST. A teaching hospital’s experience applying the PSI and antibiotics guidelines in the management of community-acquired pneumonia. Respirology. 2007;12(5):754–758. doi: 10.1111/j.1440-1843.2007.01121.x. [DOI] [PubMed] [Google Scholar]
- 28.Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med. 2001;110(6):451–457. doi: 10.1016/s0002-9343(00)00744-0. [DOI] [PubMed] [Google Scholar]
- 29.Werner RM, Bradlow ET. Relationship between Medicare’s hospital compare performance measures and mortality rates. JAMA. 2006;296(22):2694–2702. doi: 10.1001/jama.296.22.2694. [DOI] [PubMed] [Google Scholar]
- 30.van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG. International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol. 2007;60(8):834–838. doi: 10.1016/j.jclinepi.2006.10.018. [DOI] [PubMed] [Google Scholar]
- 31.Gedeborg R, Furebring M, Michaëlsson K. Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol. 2007;60(2):155–162. doi: 10.1016/j.jclinepi.2006.05.013. [DOI] [PubMed] [Google Scholar]
- 32.Whittle J, Fine MJ, Joyce DZ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual. 1997;12(4):187–193. doi: 10.1177/0885713X9701200404. [DOI] [PubMed] [Google Scholar]
- 33.Aronsky D, Haug PJ, Lagor C, Dean NC. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual. 2005;20(6):319–328. doi: 10.1177/1062860605280358. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.